Atlas Trials

ET-01 in Subjects With Lateral Canthal Lines, LCL-207

Clinical trial NCT03655691 · COMPLETED

Trial details

NCT number
NCT03655691
Sponsor
Eirion Therapeutics Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lateral Canthal LinesCrow's Feet
Start date
2018-08-16
Primary completion
2018-11-09
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.